Research News

SRM AP Pro VC Prof. Narayana Rao presenting memento to UTI President, Vistasp Karbhari

December 03, 2018: In a joint discussion presided by SRM AP Pro VC Prof. Narayana Rao, Registrar D. Gunasekaran, SRM AP faculty and staff, Pranesh Aswath, UTI Vice Provost for Academic Planning and Policy, UTI President Karbhari spoke of how, in face of global changes in education and workforce demands, education must adapt in modality with a flexible and adaptive curriculum. Karbhari explained the strides UTI has made in these critical areas.

Dr. Anil K. Suresh, Principal Investigator, Associate Professor, Biological Sciences with SRM AP Pro VC Prof. Narayana Rao

A newly established research facility in the main academic block will house advanced equipment for research related to applications like cellular culture, drug delivery, cell imagingand cell cytotoxicity.  Dr. Anil K. Suresh, Principal Investigator of the cell culture laboratory who is currently an Associate Professor at the department of Biological Sciences spearheaded the acquisition of lab equipment such as the Type 2 biosafety cabinet, CO₂ incubators, cell counting machine, inverted and upright microscopes, table-top centrifuge, – 20 and 4 degree refrigerators and cell storage facility.

The Robert Bosch Engineering and Business Solutions Pv.t Ltd in Bangalore along with SRM AP will set up a centre at SRM Amaravati to carry out research in Artificial Intelligence for health care. SRM AP Pro Vice Chancellor Dr. D. Narayana Rao and BOSCH Bangalore have been in discussions on this initiative that will bring together researchers from SRM AP’s engineering program and Bosch, a leading supplier of technology and services in mobility solutions, industrial technology and energy.

“Problems in the world are not discipline specific. Universities need a wider scope in research,” was one of the points raised by Prasant Mohapatra, member of SRM AP Board of Governors, in his symposium on research methodologies. “Research responds to societal needs. To remain contemporary and dynamic it is necessary to reinforce it regularly with current best practices.”

For a study published in JAMA (Journal of the American Medical Association – Impact factor – 47.661), SRM AP Associate Dean of SLABS, Professor Shailender Swaminathan, and US based colleagues (Benjamin D. Sommers, Rebecca Thorsness, Rajnish Mehrotra, Yoojin Lee, and Amal N. Trivedi) used a U.S.national registry to identify patients 19-64 with newly developed end stage renal disease who had initiated dialysis in a 6 year period 2011-2017.